Eli Lilly will spend $5.3 billion to boost manufacturing capacity for its anti-obesity drug Zepbound and cousin diabetes drug Mounjaro. 0 25.05.2024 07:01 The Wall Street Journal Eli Lilly will spend $5.3 billion to boost manufacturing capacity for its anti-obesity drug Zepbound and cousin diabetes drug Mounjaro. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
